Exhibitors
LIFE & BRAIN GmbH is a biomedical and neurscientific technology platform founded in 2002 by the University of Bonn and Bonn Medical Center.
LIFE & BRAIN’s mission is to close the gap between academic research and business to develop new strategies for the diagnosis and therapy of nervous system disorders. As an innovation center in the field of biomedicine, LIFE & BRAIN brings together expertise in genomic research, transgenic animals, stem cell biology and neurocognition to deliver novel products for disease modeling, early diagnosis, compound development and tissue regeneration.
Olink’s mission is to accelerate proteomics together with the scientific community, to understand real-time biology and gain actionable insights into human health and disease. Our innovative solutions deliver highly sensitive and accurate protein quantification, giving scientists the power to investigate complex biological processes with precision. Olink Proteomics is a company dedicated to improving the lives of patients by enabling scientists to make breakthrough discoveries in understanding human diseases, with the help of its enabling solutions for protein biomarker research. The Olink platform is widely used
across major pharma companies and leading clinical and academic research institutions, providing actionable insights to better understand human biology and drive development of the next generation of therapeutics to improve future healthcare. Olink’s PEA (proximity extension assay) technology continues the long tradition of innovation in protein science generated in Uppsala, Sweden, culminating in the launch of the first 92-protein panel based on PEA in 2013. The technology now enables high-throughput measurement of >3000 proteins simultaneously with exceptional data quality. The company was founded in 2016 and is well established across Europe, North America and Asia. Since July 2024 Olink is part of Thermo Fisher Scientific.
For more information, please visit www.olink.com
The National Institute for Science Communication (NaWik) is a non‐profit organisation, established in 2012. NaWik stakeholders are the Klaus Tschira Foundation and the Karlsruhe Institute of Technology, KIT.
Science is an important part of our culture and scientific findings influence the future development of society. The vision of NaWik is to improve the information flow from academic research to the public with the goal of a more scientifically literate society.
NaWik trains scientists to communicate their intentions, findings and issues to a wider audience and engage with society for a dialog. For that purpose, NaWik offers a portfolio of on-site and online seminars and maintains an e-learning platform (www.nawik.de).
NaWik fosters the exchange between communicating scientists on its WissKon network (www.nawik.de/wisskon - currently only available in German), performs in-house science communication research and is a founding partner of the platform wissenschaftskommunikation.de.
Genomic data from patients are of great value for biomedical research, and increasingly also for diagnostics and personalized therapies. Extensively characterized data sets are currently generated across Germany. Integration of these local data sets is essential for their optimal use. Modern computer services such as machine learning or artificial intelligence, for example, only unfold their full potential with access to combined big data.
The need to make data open and FAIR for the research community must always be weighed against the protection of the patient's privacy. To balance data protection and data usage, GHGA (German Human Genome-Phenome Archive) operates a national infrastructure for human genome data. This allows highly sensitive genome data to be merged, saved and analyzed in a uniform, data protection-compliant framework.
GHGA is funded, alongside eight other consortia, as part of the German national program for research data infrastructures - the NFDI e.V. - by the DFG. As a national node of the federated European Genome Phenome Archive (EGA), GHGA can follow national regulations on data protection and at the same time be closely linked to international data infrastructures. Coordinated via the German Cancer Research Center (DKFZ), GHGA has 46 participants from 21 institutions.
German Network for Bioinformatics Infrastructure (de.NBI)In recent years, ever-increasing applications of omics technologies have revolutionized life science and simultaneously created the need to store, process, and analyze large amounts of data. To meet these challenges, the German Network for Bioinformatics Infrastructure (de.NBI) was established in 2015. It is funded by the German Ministry of Education and Research (BMBF) via the Forschungszentrum Jülich, a member of the Helmholtz association. The distributed academic network consists of eight thematic Service Centers comprising 24 partner institutions. We serve the life science research community by offering bioinformatic tools, training, compute resources, as well as connection to industrial companies within Germany and Europe. The tool portfolio consists of over 160 services and tools ranging from databases, web services and stand-alone tools to complete workflows for the processing and analysis of omics data. In the area of training, de.NBI offers a wide variety of training courses, webinars, and online courses on omics tools or workflows which enable researchers to turn their raw data into tangible results. Approximately, 80 training courses per year are offered to researchers and users on national and international level. Up to now, the de.NBI network has trained more than 11.000 life scientists at all qualification levels. The network also offers huge computing power and storage capacities of the federated de.NBI Cloud that allows researchers to process and analyze their own data. Simply apply for resources via our website. The de.NBI constitutes the German Node of the ESFRI ELIXIR, the European life sciences infrastructure for biological information (https://elixir-europe.org). Find more information about us at www.denbi.de